# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-23-000693
Filing Date
2023-07-07
Accepted
2023-07-07 16:15:34
Documents
98
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | igcpharma20230331_10k.htm iXBRL | 10-K | 1660926
2 | EXHIBIT 21.1 | ex_537644.htm | EX-21.1 | 31001
3 | EXHIBIT 23.1 | ex_537645.htm | EX-23.1 | 3157
4 | EXHIBIT 31.1 | ex_537646.htm | EX-31.1 | 15422
5 | EXHIBIT 31.2 | ex_537647.htm | EX-31.2 | 14769
6 | EXHIBIT 32.1 | ex_537648.htm | EX-32.1 | 7926
7 | EXHIBIT 32.2 | ex_537649.htm | EX-32.2 | 7523
13 |  | figure1.jpg | GRAPHIC | 21209
14 |  | figure5.jpg | GRAPHIC | 17128
15 |  | figure6.jpg | GRAPHIC | 18237
16 |  | figure7.jpg | GRAPHIC | 22935
17 |  | igcpharma_logo1.jpg | GRAPHIC | 8508
18 |  | pe_img1.jpg | GRAPHIC | 50439
| Complete submission text file | 0001185185-23-000693.txt |  | 7649898

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | igc-20230331.xsd | EX-101.SCH | 61591
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | igc-20230331_cal.xml | EX-101.CAL | 54223
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | igc-20230331_def.xml | EX-101.DEF | 263379
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | igc-20230331_lab.xml | EX-101.LAB | 505955
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | igc-20230331_pre.xml | EX-101.PRE | 282749
92 | EXTRACTED XBRL INSTANCE DOCUMENT | igcpharma20230331_10k_htm.xml | XML | 1087168

Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-32830 | Film No.: 231076949
SIC: 2834 Pharmaceutical Preparations